1-Methyl-7-methoxy-3,4-dihydro-β-carboline; 3,4-Dihydroharmine; 4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole; Dihydroharmine; Harmalol methyl ether; Harmidine; NSC 407285
Harmaline is a naturally occurring alkaloid primarily found in the seeds of Peganum harmala, known for its psychoactive properties. This compound has garnered significant interest in both the pharmaceutical and research sectors due to its potential applications. Harmaline acts as a reversible inhibitor of monoamine oxidase A (MAO-A), making it a valuable candidate in the study of various neuropsychiatric disorders. Its unique ability to modulate neurotransmitter levels positions it as a promising agent in the development of treatments for depression and anxiety.
In addition to its therapeutic potential, harmaline is also utilized in the field of ethnobotany and traditional medicine, where it has been employed for its psychoactive effects in various cultural rituals. Researchers are exploring its role in enhancing cognitive function and its possible applications in neuroprotection. With its multifaceted properties, harmaline stands out as a compound of interest for both academic research and practical applications in mental health therapies.
Synonyms
1-Methyl-7-methoxy-3,4-dihydro-β-carboline; 3,4-Dihydroharmine; 4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole; Dihydroharmine; Harmalol methyl ether; Harmidine; NSC 407285
Molecular Formula
C13H14N2O
Appearance
Off-white to light brown powder
NMR
Conforms to reference
Storage and Stability
May be stored at RT for short-term only. Long-term storage is recommended at 4°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards
All products should be handled by qualified personnel only, trained in laboratory procedures.